Our results also showed that the cancer cell-selective toxicity of AA was dependent on ROS, which is consistent with an increase of the mitochondrial-derived ROS in KRAS and BRAF mutant cells (Corazao-Rozas et al., 2013; Liou et al., 2016; Schoenfeld et al., 2017). The gene discussed is BRAF; the disease is cancer.